title: [Cardiovascular complications in oncology patients].
abstract: Cancer patients receiving chemotherapy have an increased risk of developing cardiovascular complications even if they have normal hearts, and the risk is greater if there is known history of heart disease. Various clinical cardiac complications that have been reported are arrhythmias, cardiomyopathy, vaso-occlusion or vasospasm resulting in angina or myocardial infarction. It is well know that cardiovascular complications in oncology patients is caused by anthracyclines. The trastuzumab as the new treatment option for the metastatic breast cancer may be associated with the development of a clinically significant cardiotoxicity. We described and reviewed the cardiotoxicity in oncology patients.
authors.affiliation: Department of Breast and Endocrine Surgery, Tokai University School of Medicine.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tokuda
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents